Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Jun 25;16(12):2248.
doi: 10.3390/ijerph16122248.

Diabetes Mellitus: An Independent Risk Factor of In-Hospital Mortality in Patients with Infective Endocarditis in a New Era of Clinical Practice

Affiliations
Observational Study

Diabetes Mellitus: An Independent Risk Factor of In-Hospital Mortality in Patients with Infective Endocarditis in a New Era of Clinical Practice

Cheng-Jei Lin et al. Int J Environ Res Public Health. .

Abstract

Infective endocarditis (IE) is a severe disease with a hospital mortality rate of 17%-25%. Early identification of IE patients with high risk of mortality may improve their clinical outcomes. Patients with diabetes mellitus (DM) who develop infective diseases are associated with worse outcomes. This study aimed to define the impact of DM on long-term mortality in IE patients. A total of 412 patients with definite IE from February 1999 to June 2012 were enrolled in this observational study and divided into 2 groups: group 1, patients with DM (n = 72) and group 2, patients without DM (n = 340). The overall in-hospital mortality rate for both groups combined was 20.2% and was higher in group 1 than in group 2 (41.7% vs. 16.5%, p < 0.01). Compared to patients without DM, patients with DM were older and associated with higher incidence of chronic diseases, less drug abuse, higher creatinine levels, and increased risk of Staphylococcus aureus infection (all p < 0.05). Moreover, they were more likely to have atypical clinical presentation and were associated with longer IE diagnosis time (all p < 0.05). In multivariable analysis, DM is an independent and significant predictor of mortality. The prognosis of IE patients with DM is still poor. Early identification and more aggressive treatment may be considered in IE patients with DM.

Keywords: diabetes mellitus; infective endocarditis; mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest

Figures

Figure 1
Figure 1
Cohort selection flowchart. The final study cohort included 412 patients diagnosed with definite infective endocarditis according to the modified Duke criteria.

References

    1. Baddour L.M., Wilson W.R., Bayer A.S., Fowler V.G., Jr., Bolger A.F., Levison M.E., Ferrieri P., Gerber M.A., Tani L.Y., Gewitz M.H., et al. Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:394–434. - PubMed
    1. Nishimura R.A., Carabello B.A., Faxon D.P., Freed M.D., Lytle B.W., O’Gara P.T., O’Rourke R.A., Shah P.M., Bonow R.O., Carabello B.A., et al. ACC/AHA 2008 guideline update on valvular heart disease: Focused update on infective endocarditis: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:887–896. - PubMed
    1. Shih C.J., Chu H., Chao P.W., Lee Y.J., Kuo S.C., Li S.Y., Tarng D.C., Yang C.Y., Yang W.C., Ou S.M., et al. Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: A nationwide population-based study. Circulation. 2014;130:1684–1691. doi: 10.1161/CIRCULATIONAHA.114.012717. - DOI - PubMed
    1. Duval X., Delahaye F., Alla F., Tattevin P., Obadia J.F., Le Moing V., Doco-Lecompte T., Celard M., Poyart C., Strady C., et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: Three successive population-based surveys. J. Am. Coll. Cardiol. 2012;59:1968–1976. doi: 10.1016/j.jacc.2012.02.029. - DOI - PubMed
    1. Sy R.W., Chawantanpipat C., Richmond D.R., Kritharides L. Thrombocytopenia and mortality in infective endocarditis. J. Am. Coll. Cardiol. 2008;51:1824–1825. doi: 10.1016/j.jacc.2008.01.034. - DOI - PubMed

Publication types